AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2016

Jan 4, 2016

5229_dirs_2016-01-04_fe71cfa7-2747-4b8c-9f75-3074256ed68a.html

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7441K

AstraZeneca PLC

04 January 2016

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 31 December 2015, Cori Bargmann, a Director of the Company notified us that, on 30 December 2015, she became interested in 2,500 AstraZeneca PLC American Depositary Shares (ADSs) at a price of $34.42 per ADS as a result of a purchase of shares on the New York Stock Exchange.

Two ADSs equal one AstraZeneca PLC Ordinary Share of $0.25.

A C N Kemp

Company Secretary

4 January 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUSUORNOAARAR